Navigation Links
GTx Announces Ostarine Improved Insulin Resistance among Elderly,Patients in a Recently Completed Phase II Clinical Trial

, without limitation, the risks that (i) GTx will not be able to commercialize its product candidates if clinical trials do not demonstrate safety and efficacy in humans; (ii) GTx may not able to obtain required regulatory approvals to commercialize its product candidates; (iii) GTx's clinical trials may not be initiated and/or completed on schedule, or at all, or may otherwise be suspended or terminated; and (iv) GTx could utilize its available cash resources sooner than it currently expects and may be unable to raise capital when needed, which would force GTx to delay, reduce or eliminate its product development programs or commercialization efforts. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. GTx's annual report on form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") on March 9, 2007, contains under the heading "Risk Factors," a more comprehensive description of these and other risks to which GTx is subject. GTx expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contact

GTx, Inc.
McDavid Stilwell, 901-523-9700
Director, Corporate Communications & Financial Analysis


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/23/2014)... 23, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" ... its Scientific Advisory Board.  The new members are ... PhD. Dr. Acker is a Senior Development ...
(Date:9/22/2014)... Spain , September 23, 2014 ... to meet health authorities, increasing rigor for trial master ... life sciences industry,s largest TMF survey to date reveals ... that plan to provide auditors with remote access to ... of TMF owners surveyed in the Veeva ...
(Date:9/22/2014)... The western European automated endoscope reprocessor ... a replacement market with fewer new installations due ... partnerships are redefining competitive landscape in western ... details about revenue forecasts, unit shipments, market share ... country. The changing landscape makes it important to ...
Breaking Medicine Technology:BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3
... 6, 2011 The American Animal Hospital Association ... ) are collaborating on a new series for online ... real-life examples, the "Solve It! Series" combines engaging content ... element of mystery. Designed by a panel of experts, ...
... 6, 2011 ContinuumRx and Mississippi Baptist Health Systems ... new home infusion pharmacy that will serve ... model designed to improve patient outcomes with a more ... partnership will not only improve our core operations and ...
Cached Medicine Technology:American Animal Hospital Association and Heska Corporation Announce New Online Continuing Education Series 2ContinuumRx Forms Healthcare Joint Venture with Mississippi Baptist Health Systems 2
(Date:9/23/2014)... September 23, 2014 Cubit Labs is ... in the Google Play Store. , The popular cross ... in March of this year, gleaning a solid 5 ... , "Sharing contacts has never been so easy and ... only a few steps." - CrackBerry.com, View full App ...
(Date:9/23/2014)... 2014 According to pictures and video ... just completed the Pittsburg 2014 Tough Mudder, ... helps fund the wounded warrior project. , According to ... the ”Tough Mudder is an endurance event series in ... created by British Special Forces to test mental as ...
(Date:9/23/2014)... FL (PRWEB) September 23, 2014 ... industry precision to the development and production of ... with Canada’s Vida Cannabis . , ... assurance, and technical expertise. They’ll also pool ... in their respective markets. , "We’re deeply impressed ...
(Date:9/23/2014)... Ale Gicqueau, President and Chairman at ... Visualization for Clinical Trials at the upcoming Pharmaceutical ... on Friday, September 26, 2014. , PhUSE is ... inception, PhUSE has expanded from its roots as a ... for the discussion of topics encompassing the work of ...
(Date:9/23/2014)... 2014 Névo takes a bold step ... and adding advanced activity tracking and phone notifications for ... distance, calories burned, and more. , http://www.nevowatch.com ... healthy habits in their busy lives to look and ... that produce healthy results, but until now, style played ...
Breaking Medicine News(10 mins):Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:Florida Medical Cannabis Leader AltMed Allies With Canada's Vida Cannabis To Build Best-in-Class Expertise 2Health News:Florida Medical Cannabis Leader AltMed Allies With Canada's Vida Cannabis To Build Best-in-Class Expertise 3Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3
... medical food bar enriched with arginine and vitamins increased the ... Arginine is an amino acid// that can produce the gas ... blood vessels. So you might think that arginine might help ... blood supply to the heart. ,In fact the ...
... daily garlic supplement comprising allicin, a purified component of ... produced by the plant, reduced// the risk of ... that allicin-containing garlic ,supplements were eventful in treating infections ... of 132 volunteers took part in the experiment, which ...
... People with some forms of rheumatism say that weather ... suggests this is not the case.// The study focused ... is characterised by pain and stiffness in the muscles, ... causes the condition, but many patients often report that ...
... of eating patterns across different countries justifies an association ... proposes that sunlight exposure may be protective against the ... the specific foods that might raise or lower breast ... researcher at the American Cancer Society (ACS) in Atlanta, ...
... of heart disease, but now researchers say that every cigarette ... attack.This is because each cigarette appears to have a startling ... ,In a study of heart attack patients, the researchers found ... developing symptoms had bigger blood clots in their arteries than ...
... study on a vaccine made from the immune system ... a promising. Dr. Johannes Vieweg, associate professor of urology ... Medical Center in Durham, tested the vaccine on 13 ... uses the men's own dendritic cells, extracted white blood ...
Cached Medicine News:Health News:Diet, Sunlight connected to Breast Cancer Risk 2
An antegrade femoral nail....
... WH, the latest in the Magnes line of ... and its full cortical coverage, provides the highest ... allowing study of a wide range of neuronal ... choice of detector configurations and can be equipped ...
... and painless method of stimulating the peripheral ... two magnetic stimulation devices, the MES-10 and ... The Hight Speed MES-10 magnetic stimulator ... 25 Hz at full power. Several ...
... are the latest innovation ... portable battery-powered EEG headboxes. ... new mechanical design, and ... standard MOBEE24plus and MOBEE32 ...
Medicine Products: